title: Effect of thyroxine therapy on bone metabolism in substituted hypothyroid patients with normal or suppressed levels of TSH.
abstract: The statement that pituitary hyperthyroidism reflects peripheral hyperthyroidism is still controversial. To evaluate a possible relationship between the calcium and the thyroid metabolism, 29 women with thyroxine (T4) substituted hypothyroidism were examined. They were separated into two groups, one with normal (0.15 to 6 mU/l) and one with suppressed TSH (less than 0.15 mU/l). All the women were judged euthyroid both by their T4 and T3 and by their clinics. The daily dose of T4 (median 0.15 mg in both groups) had been unchanged and TSH level had been stable during the previous six months. Bone mineral content (BMC) of the lumbar spine, bone mineral density (BMD) of left and right collum femoris, serum alkaline phosphatase activity (AP), serum concentration of osteocalcin (Ost) and urinary excretion of hydroxyproline/creatine (Hpr/crea) were similar in the two groups. Furthermore, sex- hormone-binding-globulin (SHBG) was equal in the two groups, but significantly higher than in normals (p less than 0.01). A significant positive correlation was found between serum Ost and Hpr/crea (p less than 0.05) indicating a balanced state where bone formation equals bone resorption. AP failed to correlate to Ost and Hpr/crea because the AP raises from both bone and liver of bone and liver metabolism whereas the two others predominantly reflect bone metabolism. SHBG, being a marker of liver metabolism, was elevated in both groups, probably because of the oral administration of T4. Our data suggest that euthyroid, T4 substituted patients have a normal calcium metabolism whether TSH levels are suppressed or not.
authors.affiliation: Department of Medicine E, Frederiksberg Hospital, Denmark.
authors.forename: A N
authors.initials: AN
authors.lastname: Gam
authors.forename: G F
authors.initials: GF
authors.lastname: Jensen
authors.forename: K
authors.initials: K
authors.lastname: Hasselstrøm
authors.forename: M
authors.initials: M
authors.lastname: Olsen
authors.forename: K S
authors.initials: KS
authors.lastname: Nielsen
mesh_terms: D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D015519:Bone Density / Q000187:drug effects; D001842:Bone and Bones / Q000187:drug effects / Q000378:metabolism*; D002118:Calcium / Q000097:blood / Q000652:urine; D003404:Creatinine / Q000097:blood; D005260:Female; D006801:Humans; D006909:Hydroxyproline / Q000652:urine; D008099:Liver / Q000378:metabolism; D008875:Middle Aged; D015675:Osteocalcin / Q000097:blood; D010710:Phosphates / Q000097:blood; D012738:Sex Hormone-Binding Globulin / Q000032:analysis; D013972:Thyrotropin / Q000097:blood*; D013974:Thyroxine / Q000494:pharmacology*; D014284:Triiodothyronine / Q000097:blood
chemical_list: D010710:Phosphates; D012738:Sex Hormone-Binding Globulin; D014284:Triiodothyronine; D015675:Osteocalcin; D013972:Thyrotropin; D003404:Creatinine; D000469:Alkaline Phosphatase; D013974:Thyroxine; D006909:Hydroxyproline; D002118:Calcium